DE69507956D1 - Zyklische keton peroxyde zubereitungen - Google Patents

Zyklische keton peroxyde zubereitungen

Info

Publication number
DE69507956D1
DE69507956D1 DE69507956T DE69507956T DE69507956D1 DE 69507956 D1 DE69507956 D1 DE 69507956D1 DE 69507956 T DE69507956 T DE 69507956T DE 69507956 T DE69507956 T DE 69507956T DE 69507956 D1 DE69507956 D1 DE 69507956D1
Authority
DE
Germany
Prior art keywords
cyclic ketone
pct
ketone peroxide
peroxyde
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69507956T
Other languages
English (en)
Other versions
DE69507956T2 (de
Inventor
Reinder Torenbeek
John Meijer
Andreas Hogt
Gerrit Bekendam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8217055&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69507956(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE69507956D1 publication Critical patent/DE69507956D1/de
Publication of DE69507956T2 publication Critical patent/DE69507956T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/25—Component parts, details or accessories; Auxiliary operations
    • B29C48/92—Measuring, controlling or regulating
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • C07D323/04—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F4/00—Polymerisation catalysts
    • C08F4/28—Oxygen or compounds releasing free oxygen
    • C08F4/32—Organic compounds
    • C08F4/38—Mixtures of peroxy-compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/50—Partial depolymerisation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/14—Peroxides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C2948/00—Indexing scheme relating to extrusion moulding
    • B29C2948/92—Measuring, controlling or regulating
    • B29C2948/92504—Controlled parameter
    • B29C2948/92704—Temperature
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/022—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the choice of material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/25—Component parts, details or accessories; Auxiliary operations
    • B29C48/36—Means for plasticising or homogenising the moulding material or forcing it through the nozzle or die
    • B29C48/395—Means for plasticising or homogenising the moulding material or forcing it through the nozzle or die using screws surrounded by a cooperating barrel, e.g. single screw extruders
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2810/00—Chemical modification of a polymer
    • C08F2810/10—Chemical modification of a polymer including a reactive processing step which leads, inter alia, to morphological and/or rheological modifications, e.g. visbreaking

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Mechanical Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
DE69507956T 1994-07-21 1995-07-14 Zyklische keton peroxyde zubereitungen Expired - Fee Related DE69507956T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94202136 1994-07-21
PCT/EP1995/002830 WO1996003397A1 (en) 1994-07-21 1995-07-14 Cyclic ketone peroxide formulations

Publications (2)

Publication Number Publication Date
DE69507956D1 true DE69507956D1 (de) 1999-04-01
DE69507956T2 DE69507956T2 (de) 1999-09-09

Family

ID=8217055

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69507956T Expired - Fee Related DE69507956T2 (de) 1994-07-21 1995-07-14 Zyklische keton peroxyde zubereitungen

Country Status (17)

Country Link
US (1) US5808110A (de)
EP (1) EP0772609B1 (de)
JP (1) JP3794701B2 (de)
KR (1) KR100441557B1 (de)
CN (1) CN1068323C (de)
AT (1) ATE176910T1 (de)
AU (1) AU686466B2 (de)
BR (1) BR9508409A (de)
CA (1) CA2195537C (de)
CZ (1) CZ18497A3 (de)
DE (1) DE69507956T2 (de)
HU (1) HU216142B (de)
MX (1) MX9700535A (de)
PL (1) PL179659B1 (de)
RU (1) RU2154649C2 (de)
TW (1) TW414709B (de)
WO (1) WO1996003397A1 (de)

Families Citing this family (176)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR001122A1 (es) * 1995-03-06 1997-09-24 Akzo Nobel Nv Procedimiento de polímerizacion que utiliza una composición de peróxidos (co)polímero funcionalizadoobtenido por el proceso y uso de una composición de peróxidos
JP3991439B2 (ja) * 1997-08-04 2007-10-17 東レ株式会社 繊維強化プラスチックおよび繊維強化プラスチックの成形方法
ID25464A (id) * 1997-12-22 2000-10-05 Akzo Nobel Nv Bahan bakar dengan penyalaan yang disempurnakan
GB9809108D0 (en) * 1998-04-30 1998-07-01 British Nuclear Fuels Plc Dimer
RU2224756C2 (ru) * 1998-10-16 2004-02-27 Акцо Нобель Н.В. Улучшенная флегматизация циклических пероксидов кетона
AU2001256204A1 (en) * 2000-03-16 2001-09-24 Basell Polyolefine Gmbh Method for the production of polyethylene
KR100819680B1 (ko) 2000-08-15 2008-04-04 아크조 노벨 엔.브이. 트리옥세판 화합물
EP1186618A1 (de) * 2000-09-08 2002-03-13 ATOFINA Research Heterophasische Propylenpolymere mit kontrollierten rheologischen Werten
EP1216991A1 (de) * 2000-12-22 2002-06-26 Akzo Nobel N.V. Transportable reaktive Phlegmatisierungsmittel enthaltende organische Peroxidzusammensetzungen und ihre sichere Verpackung
EP1219602A1 (de) 2000-12-29 2002-07-03 Akzo Nobel N.V. Methylisopropylketonperoxidformulierungen und ihre Verwendung zur Härtung ungesättigter Polyester
ES2264452T3 (es) * 2000-12-29 2007-01-01 Akzo Nobel N.V. Formulaciones de peroxido de metil-propil-cetona y su uso para curar poliesteres insaturados.
US6762208B2 (en) 2001-10-01 2004-07-13 Air Products And Chemicals, Inc. Alkane diol foam controlling agents
EP1312617A1 (de) 2001-11-14 2003-05-21 ATOFINA Research Schlagzähes Polypropen
US20040132101A1 (en) 2002-09-27 2004-07-08 Xencor Optimized Fc variants and methods for their generation
JP5069843B2 (ja) 2002-07-15 2012-11-07 ジェネンテック， インコーポレイテッド 抗ＥｒｂＢ２抗体を用いる処置に応答性である腫瘍を同定するための方法
KR100960560B1 (ko) 2002-09-27 2010-06-03 젠코어 인코포레이티드 최적화된 Ｆｃ 변이체 및 그의 제조 방법
CN1720241B (zh) * 2002-12-06 2010-10-06 阿克佐诺贝尔股份有限公司 环酮过氧化物配制剂
US7252784B2 (en) 2002-12-06 2007-08-07 Akzo Nobel N.V. Cyclic ketone peroxide formulations
BRPI0407472B1 (pt) 2003-02-13 2015-07-07 Akzo Nobel Nv Composições de peróxidos de cetonas cíclicos estáveis ao armazenamento
EP1447404A1 (de) * 2003-02-13 2004-08-18 Akzo Nobel N.V. Verbesserte Zyclische Keton Peroxyde Zusammenstellungen
ES2697327T3 (es) 2003-11-06 2019-01-23 Seattle Genetics Inc Compuesto intermedio para la preparación de conjugados que comprenden derivados de auristatina y un enlazador
BRPI0510883B8 (pt) 2004-06-01 2021-05-25 Genentech Inc composto conjugado de droga e anticorpo, composição farmacêutica, método de fabricação de composto conjugado de droga e anticorpo e usos de uma formulação, de um conjugado de droga e anticorpo e um agente quimioterapêutico e de uma combinação
DE102004029732A1 (de) 2004-06-21 2006-01-19 Basf Ag Hilfsmittel enthaltend Cyclohexanpolycarbonsäurederivate
EP2940043A1 (de) 2004-07-15 2015-11-04 Xencor, Inc. Optimierte fc-varianten
PL1791565T3 (pl) 2004-09-23 2016-10-31 Modyfikowane cysteiną przeciwciała i koniugaty
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
CN101163503B (zh) 2005-02-23 2013-05-08 健泰科生物技术公司 使用her二聚化抑制剂在癌症患者中延长病情进展前时间或存活
PL1991601T3 (pl) 2006-03-03 2011-02-28 Akzo Nobel Chemicals Int Bv Sposób modyfikowania biodegradowalnych polimerów
SI2383297T1 (sl) 2006-08-14 2013-06-28 Xencor Inc. Optimizirana antitelesa, ki ciljajo cd19
US20100008910A1 (en) 2006-09-12 2010-01-14 John Chant Methods and compositions for the diagnosis and treatment of cancer
EP2899541A1 (de) 2007-03-02 2015-07-29 Genentech, Inc. Voraussage der Reaktion auf einen HRE-Dimerisationshemmer auf Basis niedriger HER3-Expression
WO2008150494A1 (en) 2007-05-30 2008-12-11 Xencor, Inc. Methods and compositions for inhibiting cd32b expressing cells
CA3006428A1 (en) 2007-06-08 2008-12-18 Genentech, Inc. Gene expression markers of tumor resistance to her2 inhibitor treatment
TWI472339B (zh) 2008-01-30 2015-02-11 Genentech Inc 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物
DE102009002652A1 (de) * 2009-04-27 2010-10-28 BAM Bundesanstalt für Materialforschung und -prüfung Triacetontriperoxid und Diacetondiperoxid-Derivat, Verfahren zu ihrer Herstellung sowie ihre Verwendung
WO2010151508A1 (en) * 2009-06-23 2010-12-29 Dow Global Technologies Inc. Controlled-rheology polypropylene
US9345661B2 (en) 2009-07-31 2016-05-24 Genentech, Inc. Subcutaneous anti-HER2 antibody formulations and uses thereof
EP3778917A3 (de) 2009-12-04 2021-06-09 F. Hoffmann-La Roche AG Multispezifische antikörper, antikörperanaloge, zusammensetzungen und verfahren
WO2011086053A1 (en) 2010-01-12 2011-07-21 F. Hoffmann-La Roche Ag Tricyclic heterocyclic compounds, compositions and methods of use thereof
JP2013522267A (ja) 2010-03-17 2013-06-13 エフ．ホフマン−ラ ロシュ アーゲー イミダゾピリジン化合物、組成物、および使用法
JP2013523098A (ja) 2010-03-29 2013-06-17 ザイムワークス，インコーポレイテッド 強化又は抑制されたエフェクター機能を有する抗体
EP2558864A1 (de) 2010-04-16 2013-02-20 Genentech, Inc. Fox03a als prädiktiver biomarker zur hemmung des pi3k/akt-kinasesignalweges
WO2011146568A1 (en) 2010-05-19 2011-11-24 Genentech, Inc. Predicting response to a her inhibitor
US8697708B2 (en) 2010-09-15 2014-04-15 F. Hoffmann-La Roche Ag Azabenzothiazole compounds, compositions and methods of use
US9309322B2 (en) 2010-11-12 2016-04-12 Scott & White Healthcare (Swh) Antibodies to tumor endothelial marker 8
EP2640722B1 (de) 2010-11-19 2015-11-04 F.Hoffmann-La Roche Ag Pyrazolpyridine sowie ihre verwendung als tyk2 inhibitoren
WO2012085176A1 (en) 2010-12-23 2012-06-28 F. Hoffmann-La Roche Ag Tricyclic pyrazinone compounds, compositions and methods of use thereof as janus kinase inhibitors
FR2971510B1 (fr) * 2011-02-10 2013-03-22 Arkema France Polymerisation radicalaire de l'ethylene amorcee par des peroxydes organiques a haute productivite
WO2012122513A2 (en) 2011-03-10 2012-09-13 Omeros Corporation Generation of anti-fn14 monoclonal antibodies by ex-vivo accelerated antibody evolution
WO2013007765A1 (en) 2011-07-13 2013-01-17 F. Hoffmann-La Roche Ag Fused tricyclic compounds for use as inhibitors of janus kinases
WO2013007768A1 (en) 2011-07-13 2013-01-17 F. Hoffmann-La Roche Ag Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors
MX2014001595A (es) 2011-08-12 2014-04-14 Hoffmann La Roche Compuestos de imidazol, composiciones y metodos de uso.
AU2012295394B2 (en) 2011-08-12 2016-04-14 Omeros Corporation Anti-FZD10 monoclonal antibodies and methods for their use
CA2845409A1 (en) 2011-09-20 2013-03-28 Yingjie Lai Imidazopyridine compounds, compositions and methods of use
CN102584782A (zh) * 2011-12-31 2012-07-18 北京理工大学 过氧化丙酮四聚体的制备方法
KR20170036142A (ko) 2012-03-08 2017-03-31 할로자임, 아이엔씨 조건부 활성 항-표피 성장 인자 수용체 항체 및 이의 사용 방법
RU2014136886A (ru) 2012-03-27 2016-05-20 Дженентек, Инк. Диагностика и виды лечения, связанные с ингибиторами her3
CN104520368B (zh) * 2012-08-17 2016-12-14 阿克佐诺贝尔化学国际公司 固化热固性树脂的方法
WO2014027007A2 (en) * 2012-08-17 2014-02-20 Akzo Nobel Chemicals International B.V. Process for curing thermoset resins
DE102013112821A1 (de) 2012-11-30 2014-06-05 Shell Internationale Research Maatschappij B.V. Kraftstoffzusammensetzungen
AR093663A1 (es) * 2012-12-05 2015-06-17 Akzo Nobel Chemicals Int Bv Lote maestro de peroxido basado en bioresina
MY178742A (en) * 2012-12-05 2020-10-20 Akzo Nobel Chemicals Int Bv Masterbatch comprising a cyclic ketone peroxide
US10316162B2 (en) 2012-12-05 2019-06-11 Akzo Nobel Chemicals International B.V. Masterbatch comprising a cyclic ketone peroxide
CN104822751B (zh) * 2012-12-05 2017-05-10 阿克佐诺贝尔化学国际公司 基于生物树脂的过氧化物母体混合物
AR093664A1 (es) * 2012-12-05 2015-06-17 Akzo Nobel Chemicals Int Bv Mezcla madre formada por un peroxido de cetona ciclico
ES2709724T3 (es) * 2012-12-05 2019-04-17 Akzo Nobel Chemicals Int Bv Mezcla madre de peróxido basada en biorresina
CN104884584B (zh) 2012-12-21 2017-03-08 国际壳牌研究有限公司 含有有机遮光化合物的液体柴油燃料组合物
CA2922925A1 (en) 2013-09-05 2015-03-12 Genentech, Inc. Antiproliferative compounds
WO2015049325A1 (en) 2013-10-03 2015-04-09 F. Hoffmann-La Roche Ag Therapeutic inhibitors of cdk8 and uses thereof
CN105658774B (zh) 2013-10-24 2018-04-06 国际壳牌研究有限公司 液体燃料组合物
CN105814176B (zh) 2013-12-16 2017-08-15 国际壳牌研究有限公司 液体燃料组合物
SG11201604979WA (en) 2013-12-17 2016-07-28 Genentech Inc Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonists
ES2763429T5 (es) 2013-12-17 2023-06-21 Hoffmann La Roche Procedimientos de tratamiento de cánceres usando antagonistas de la unión al eje de PD-1 y taxanos
EP3116865B1 (de) * 2014-03-11 2017-11-15 Akzo Nobel Chemicals International B.V. Zyklische ketonperoxydzusammensetzung
WO2015153514A1 (en) 2014-03-31 2015-10-08 Genentech, Inc. Combination therapy comprising anti-angiogenesis agents and ox40 binding agonists
SG11201607969XA (en) 2014-03-31 2016-10-28 Genentech Inc Anti-ox40 antibodies and methods of use
EP2949732B1 (de) 2014-05-28 2018-06-20 Shell International Research Maatschappij B.V. Verwendung einer oxanilid-verbindung in einer dieselkraftstoffzusammensetzung für den zweck der modifizierung der zündverzögerung und/oder der brenndauer
FR3022251A1 (fr) * 2014-06-13 2015-12-18 Arkema France Solvant organique pour peroxydes
EP3189046B1 (de) 2014-09-05 2020-08-26 Genentech, Inc. Therapeutische verbindungen und ihre verwendung
EP3193866A1 (de) 2014-09-19 2017-07-26 Genentech, Inc. Verwendung von cbp/ep300- und bet-inhibitoren zur behandlung von krebs
JP6783230B2 (ja) 2014-10-10 2020-11-11 ジェネンテック， インコーポレイテッド ヒストンデメチラーゼのインヒビターとしてのピロリドンアミド化合物
SG11201703448QA (en) 2014-11-03 2017-05-30 Genentech Inc Assays for detecting t cell immune subsets and methods of use thereof
KR20170072343A (ko) 2014-11-06 2017-06-26 제넨테크, 인크. Ox40 결합 효능제 및 tigit 억제제를 포함하는 병용 요법
MA40943A (fr) 2014-11-10 2017-09-19 Constellation Pharmaceuticals Inc Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
MA40940A (fr) 2014-11-10 2017-09-19 Constellation Pharmaceuticals Inc Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
JP6639497B2 (ja) 2014-11-10 2020-02-05 ジェネンテック， インコーポレイテッド ブロモドメインインヒビターおよびその使用
SG11201703605QA (en) 2014-11-17 2017-06-29 Genentech Inc Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonists
EP3632915A1 (de) 2014-11-27 2020-04-08 Genentech, Inc. 4,5,6,7-tetrahydro-1-h-pyrazolo[4,3-c]pyridin-3-amin-verbindungen als cbp- und/oder ep300-inhibitoren
WO2016106340A2 (en) 2014-12-23 2016-06-30 Genentech, Inc. Compositions and methods for treating and diagnosing chemotherapy-resistant cancers
JP2018503373A (ja) 2014-12-30 2018-02-08 ジェネンテック， インコーポレイテッド がんの予後診断及び治療のための方法及び組成物
CN107406429B (zh) 2015-01-09 2021-07-06 基因泰克公司 哒嗪酮衍生物及其在治疗癌症中的用途
CN107406414B (zh) 2015-01-09 2022-04-19 基因泰克公司 作为用于治疗癌症的组蛋白脱甲基酶kdm2b的抑制剂的(哌啶-3-基)(萘-2-基)甲酮衍生物
EP3242875B1 (de) 2015-01-09 2022-02-23 Genentech, Inc. 4,5-dihydroimidazol- derivate und ihre verwendung als histone demethylase (kdm2b) inhibitoren
WO2016123391A1 (en) 2015-01-29 2016-08-04 Genentech, Inc. Therapeutic compounds and uses thereof
CN107438593B (zh) 2015-01-30 2020-10-30 基因泰克公司 治疗化合物及其用途
MA41598A (fr) 2015-02-25 2018-01-02 Constellation Pharmaceuticals Inc Composés thérapeutiques de pyridazine et leurs utilisations
WO2016164480A1 (en) 2015-04-07 2016-10-13 Genentech, Inc. Antigen binding complex having agonistic activity and methods of use
AU2016270625B2 (en) 2015-05-29 2022-10-06 Genentech, Inc. Therapeutic and diagnostic methods for cancer
JP2018521019A (ja) 2015-06-08 2018-08-02 ジェネンテック， インコーポレイテッド 抗ｏｘ４０抗体を使用して癌を治療する方法
CA2988420A1 (en) 2015-06-08 2016-12-15 Genentech, Inc. Methods of treating cancer using anti-ox40 antibodies and pd-1 axis binding antagonists
EP3310815A1 (de) 2015-06-17 2018-04-25 F. Hoffmann-La Roche AG Verfahren zur behandlung von lokal fortgeschrittenen oder metastatischen brustkrebsen unter verwendung von pd-1-achse-bindenden antagonisten und taxanen
PL3341376T3 (pl) 2015-08-26 2021-08-02 Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncológicas Carlos III (F.S.P. CNIO) Skondensowane związki tricykliczne jako inhibitory kinaz białkowych
EP3374471B1 (de) 2015-11-11 2020-10-28 Shell International Research Maatschappij B.V. Verfahren zur herstellung einer dieselkraftstoffzusammensetzung
KR20180097615A (ko) 2016-01-08 2018-08-31 에프. 호프만-라 로슈 아게 Pd-1 축 결합 길항물질 및 항-cea/항-cd3 이중특이성 항체를 사용하는 cea-양성 암의 치료 방법
CN114395624A (zh) 2016-02-29 2022-04-26 基因泰克公司 用于癌症的治疗和诊断方法
AU2017249229A1 (en) 2016-04-15 2018-10-04 Genentech, Inc. Diagnostic and therapeutic methods for cancer
EP3443120A2 (de) 2016-04-15 2019-02-20 H. Hoffnabb-La Roche Ag Verfahren zur überwachung und behandlung von krebs
KR20190003958A (ko) 2016-04-15 2019-01-10 제넨테크, 인크. 암의 치료 및 모니터링 방법
EP3454863A1 (de) 2016-05-10 2019-03-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Kombinationstherapien zur behandlung von krebs
EP3464286B1 (de) 2016-05-24 2021-08-18 Genentech, Inc. Pyrazolopyridinderivate zur behandlung von krebs
JP7160688B2 (ja) 2016-05-24 2022-10-25 ジェネンテック， インコーポレイテッド Ｃｂｐ／ｅｐ３００の複素環式インヒビターおよびがんの処置におけるそれらの使用
US20200129519A1 (en) 2016-06-08 2020-04-30 Genentech, Inc. Diagnostic and therapeutic methods for cancer
EP3468997B1 (de) 2016-06-08 2023-09-13 Xencor, Inc. Behandlung von erkrankungen im zusammenhang mit igg4 mit anti-cd19-antikörpern mit kreuzbindung an cd32b
CN109963871A (zh) 2016-08-05 2019-07-02 豪夫迈·罗氏有限公司 具有激动活性的多价及多表位抗体以及使用方法
WO2018029124A1 (en) 2016-08-08 2018-02-15 F. Hoffmann-La Roche Ag Therapeutic and diagnostic methods for cancer
CN110418851A (zh) 2016-10-06 2019-11-05 基因泰克公司 癌症的治疗和诊断方法
WO2018077976A1 (en) 2016-10-27 2018-05-03 Shell Internationale Research Maatschappij B.V. Process for preparing an automotive gasoil
CN110267678A (zh) 2016-10-29 2019-09-20 霍夫曼-拉罗奇有限公司 抗mic抗体和使用方法
FR3060011B1 (fr) * 2016-12-08 2020-06-26 Arkema France Agent de durcissement pour durcir une resine de polymere
WO2018206729A1 (en) 2017-05-11 2018-11-15 Shell Internationale Research Maatschappij B.V. Process for preparing an automotive gas oil fraction
WO2019084395A1 (en) 2017-10-27 2019-05-02 University Of Virginia Patent Foundation COMPOUNDS AND METHODS FOR REGULATING, LIMITING OR INHIBITING AVIL EXPRESSION
TW201923089A (zh) 2017-11-06 2019-06-16 美商建南德克公司 癌症之診斷及治療方法
US11332620B2 (en) * 2018-03-13 2022-05-17 Nouryon Chemicals International B.V. Solution comprising a dye
CN108586802A (zh) * 2018-05-28 2018-09-28 广州印田新材料有限公司 含有酯类减敏剂的稳定环酮过氧化物组合物的制备方法
CN108503885A (zh) * 2018-05-28 2018-09-07 广州印田新材料有限公司 一种含有酯类减敏剂的稳定的环酮过氧化物组合物
CA3103017A1 (en) 2018-06-23 2019-12-26 Genentech, Inc. Methods of treating lung cancer with a pd-1 axis binding antagonist, a platinum agent, and a topoisomerase ii inhibitor
US11499107B2 (en) 2018-07-02 2022-11-15 Shell Usa, Inc. Liquid fuel compositions
US20200171146A1 (en) 2018-07-18 2020-06-04 Genentech, Inc. Methods of treating lung cancer with a pd-1 axis binding antagonist, an antimetabolite, and a platinum agent
CN112805267B (zh) 2018-09-03 2024-03-08 豪夫迈·罗氏有限公司 用作tead调节剂的甲酰胺和磺酰胺衍生物
MX2021003214A (es) 2018-09-19 2021-05-12 Genentech Inc Metodos terapeuticos y de diagnostico para el cancer de vejiga.
PL3857230T3 (pl) 2018-09-21 2023-10-16 F. Hoffmann-La Roche Ag Sposoby diagnostyczne dla potrójnie ujemnego raka piersi
KR20210079311A (ko) 2018-10-18 2021-06-29 제넨테크, 인크. 육종성 신장암에 대한 진단과 치료 방법
EP3921443A1 (de) 2019-02-08 2021-12-15 F. Hoffmann-La Roche AG Diagnose- und therapieverfahren für krebs
KR20210133237A (ko) 2019-02-27 2021-11-05 제넨테크, 인크. 항-tigit 및 항-cd20 또는 항-cd38 항체로 치료를 위한 투약
WO2020223233A1 (en) 2019-04-30 2020-11-05 Genentech, Inc. Prognostic and therapeutic methods for colorectal cancer
JP2022530674A (ja) 2019-05-03 2022-06-30 ジェネンテック， インコーポレイテッド 抗ｐｄ－ｌ１抗体を用いたがんの処置方法
CN112300279A (zh) 2019-07-26 2021-02-02 上海复宏汉霖生物技术股份有限公司 针对抗cd73抗体和变体的方法和组合物
MX2022002738A (es) 2019-09-04 2022-06-27 Genentech Inc Agentes de union a cd8 y uso de los mismos.
US20220315579A1 (en) 2019-09-26 2022-10-06 Exelixis, Inc. Pyridone compounds and methods of use
FR3101349B1 (fr) * 2019-09-27 2022-02-25 Arkema France Composition anhydre solide sous forme de poudre comprenant au moins un peroxyde organique, au moins un agent flegmatisant et au moins un liant et procédé préparation correspondant
AU2020351734A1 (en) 2019-09-27 2022-04-14 Genentech, Inc. Dosing for treatment with anti-TIGIT and anti-PD-L1 antagonist antibodies
WO2021083949A1 (en) 2019-10-29 2021-05-06 F. Hoffmann-La Roche Ag Bifunctional compounds for the treatment of cancer
AU2020378330A1 (en) 2019-11-06 2022-05-12 F. Hoffmann-La Roche Ag Diagnostic and therapeutic methods for treatment of hematologic cancers
CR20220207A (es) 2019-11-13 2022-06-06 Genentech Inc Compuestos terapéuticos y métodos de uso
IL293423A (en) 2019-12-13 2022-07-01 Genentech Inc Anti-ly6g6d antibodies and methods of use
WO2021194481A1 (en) 2020-03-24 2021-09-30 Genentech, Inc. Dosing for treatment with anti-tigit and anti-pd-l1 antagonist antibodies
AU2021212662A1 (en) 2020-01-27 2022-08-11 F. Hoffmann-La Roche Ag Methods for treatment of cancer with an anti-TIGIT antagonist antibody
WO2022050954A1 (en) 2020-09-04 2022-03-10 Genentech, Inc. Dosing for treatment with anti-tigit and anti-pd-l1 antagonist antibodies
WO2021177980A1 (en) 2020-03-06 2021-09-10 Genentech, Inc. Combination therapy for cancer comprising pd-1 axis binding antagonist and il6 antagonist
CN115698717A (zh) 2020-04-03 2023-02-03 基因泰克公司 癌症的治疗和诊断方法
EP4143345A1 (de) 2020-04-28 2023-03-08 Genentech, Inc. Verfahren und zusammensetzungen zur immuntherapie gegen nicht-kleinzelligen lungenkrebs
MX2022015877A (es) 2020-06-16 2023-01-24 Genentech Inc Metodos y composiciones para tratar cancer de mama triple negativo.
JP2023531200A (ja) 2020-06-18 2023-07-21 ジェネンテック， インコーポレイテッド 抗ｔｉｇｉｔ抗体及びｐｄ－１軸結合アンタゴニストを用いた治療
US20230266322A1 (en) 2020-06-30 2023-08-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapy and radical surgery
WO2022002873A1 (en) 2020-06-30 2022-01-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapies
US11787775B2 (en) 2020-07-24 2023-10-17 Genentech, Inc. Therapeutic compounds and methods of use
CN116568824A (zh) 2020-08-03 2023-08-08 基因泰克公司 淋巴瘤的诊断和治疗方法
EP4196612A1 (de) 2020-08-12 2023-06-21 Genentech, Inc. Diagnostische und therapeutische verfahren für krebs
EP4217071A1 (de) 2020-09-23 2023-08-02 Erasca, Inc. Tricyclische pyridone und pyrimidone
CA3193952A1 (en) 2020-10-05 2022-04-14 Bernard Martin Fine Dosing for treatment with anti-fcrh5/anti-cd3 bispecific antibodies
WO2022133345A1 (en) 2020-12-18 2022-06-23 Erasca, Inc. Tricyclic pyridones and pyrimidones
MX2023009379A (es) 2021-02-12 2023-10-10 Hoffmann La Roche Derivados de tetrahidroazepina biciclicos para el tratamiento del cancer.
WO2022178205A1 (en) 2021-02-19 2022-08-25 Exelixis, Inc. Pyridone compounds and methods of use
AU2022280025A1 (en) 2021-05-25 2023-12-07 Erasca, Inc. Sulfur-containing heteroaromatic tricyclic kras inhibitors
WO2022266206A1 (en) 2021-06-16 2022-12-22 Erasca, Inc. Kras inhibitor conjugates
EP4384522A1 (de) 2021-08-10 2024-06-19 Erasca, Inc. Selektive kras-hemmer
US20230202984A1 (en) 2021-11-24 2023-06-29 Genentech, Inc. Therapeutic compounds and methods of use
WO2023191816A1 (en) 2022-04-01 2023-10-05 Genentech, Inc. Dosing for treatment with anti-fcrh5/anti-cd3 bispecific antibodies
WO2023219613A1 (en) 2022-05-11 2023-11-16 Genentech, Inc. Dosing for treatment with anti-fcrh5/anti-cd3 bispecific antibodies
WO2023240058A2 (en) 2022-06-07 2023-12-14 Genentech, Inc. Prognostic and therapeutic methods for cancer
WO2024015897A1 (en) 2022-07-13 2024-01-18 Genentech, Inc. Dosing for treatment with anti-fcrh5/anti-cd3 bispecific antibodies
WO2024033388A1 (en) 2022-08-11 2024-02-15 F. Hoffmann-La Roche Ag Bicyclic tetrahydrothiazepine derivatives
WO2024033458A1 (en) 2022-08-11 2024-02-15 F. Hoffmann-La Roche Ag Bicyclic tetrahydroazepine derivatives
WO2024033457A1 (en) 2022-08-11 2024-02-15 F. Hoffmann-La Roche Ag Bicyclic tetrahydrothiazepine derivatives
WO2024033389A1 (en) 2022-08-11 2024-02-15 F. Hoffmann-La Roche Ag Bicyclic tetrahydrothiazepine derivatives
WO2024091991A1 (en) 2022-10-25 2024-05-02 Genentech, Inc. Therapeutic and diagnostic methods for multiple myeloma

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB827511A (en) * 1957-02-07 1960-02-03 Laporte Chemical Improvements in or relating to methyl ethyl ketone peroxides
US3003000A (en) * 1959-07-01 1961-10-03 Research Corp Organic peroxides
GB912061A (en) * 1959-09-01 1962-12-05 Laporte Chemical Improvements in or relating to the manufacture of ketone peroxides
GB1072728A (en) * 1965-11-17 1967-06-21 Wallace & Tiernan Inc Stabilised ketone peroxide compositions
US3649546A (en) * 1967-05-15 1972-03-14 Norac Co Non-hazardous ketone peroxide polymerization initiators
US3867461A (en) * 1968-02-05 1975-02-18 Argus Chem Non-hazardous ketone peroxide compositions
AT319589B (de) * 1972-07-25 1974-12-27 Chemie Linz Ag Verfahren zur Herstellung von Polypropylen
TR17756A (tr) * 1972-07-25 1976-07-01 Oesterr Stickstoffwerke Ag Mahdut molekuel agirligi dagilisina sahip polipropilenin imal edilmesine mahsus usul
DE2660923C2 (de) * 1975-06-30 1987-03-19 Argus Chemical Corp., New York, N.Y., Us
US4271279A (en) * 1975-06-30 1981-06-02 Argus Chemical Corporation Cyclic perketals and their use for cross-linking high density polyethylene
IT1104579B (it) * 1978-12-29 1985-10-21 Montedison Spa Procedimento per la preparazione di miscele ferossidiche
NL8502042A (nl) * 1985-07-16 1985-10-01 Akzo Nv Nieuwe geflegmatiseerde keton peroxide samenstellingen en hun toepassing bij de vervaardiging van gietkernen of -vormen.
US4956416A (en) * 1988-08-18 1990-09-11 Atochem North America, Inc. Amino or hydrazino peroxides, derivatives and their uses

Also Published As

Publication number Publication date
PL318322A1 (en) 1997-06-09
ATE176910T1 (de) 1999-03-15
JP3794701B2 (ja) 2006-07-12
PL179659B1 (pl) 2000-10-31
AU3643795A (en) 1996-02-22
CN1153514A (zh) 1997-07-02
DE69507956T2 (de) 1999-09-09
US5808110A (en) 1998-09-15
CN1068323C (zh) 2001-07-11
JPH10503229A (ja) 1998-03-24
HUT77800A (hu) 1998-08-28
EP0772609A1 (de) 1997-05-14
AU686466B2 (en) 1998-02-05
CA2195537C (en) 2006-09-12
KR970704727A (ko) 1997-09-06
MX9700535A (es) 1997-04-30
RU2154649C2 (ru) 2000-08-20
KR100441557B1 (ko) 2005-08-05
EP0772609B1 (de) 1999-02-24
BR9508409A (pt) 1997-12-23
WO1996003397A1 (en) 1996-02-08
TW414709B (en) 2000-12-11
HU216142B (hu) 1999-04-28
CZ18497A3 (en) 1997-07-16
CA2195537A1 (en) 1996-02-08

Similar Documents

Publication Publication Date Title
DE69507956D1 (de) Zyklische keton peroxyde zubereitungen
ATE169317T1 (de) Pyridobismidazole enthaltendes rigid-rod-polymer
MX9603560A (es) Composiciones de prostaglandinas estables en almacenamiento.
DK0771330T3 (da) Modificering af (co)polymerer med cykliske ketonperoxider
FI960546A0 (fi) Polymeerin stabilointi stabiililla vapaalla radikaalilla
ES2128469T3 (es) Polimeros de funcionalidad carbamato curables.
DE69933147D1 (de) Sustiuierte cyclische verbindungen, verfahren zu ihrer herstellung sowie sie enthaltende pharmazeutische zusammesetzungen
CA2214674A1 (en) Cyclic ketone peroxides as polymerization initiators
DE69318636D1 (de) Substituierte Aminothienopyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CA2080820A1 (fr) Derives azoiques, compositions pharmaceutiques et desinfectantes les contenant et leurs utilisations
FI960137A (fi) UV-vulkanoitava lohkokopolymeerikoostumus
TW349104B (en) A base resin for use in chemically amplified resist and a manufacturing method thereof the invention relates to a base resin for use in a chemically amplified resist and a manufacturing method thereof, the base resin containing two t-butyl groups
MY115690A (en) Cyclic ketone peroxide formulations
CA2061995A1 (en) Use of oxime ether derivatives for bioregulation in plants
ES2067552T3 (es) Estratificados de espuma rigida de poliuretano de celdillas cerradas.
AR000079A1 (es) Composíción de peróxido transportable estable durante el almacenamiento, y uso de la composición.
FI963055A (fi) Kondensaatio- ja additiopolymeereja, jotka sisältävät N,N'-sillan sisältäviä bis(tetrametyylipiperidinyylioksi)-ryhmiä
UA33144A (uk) Гумова суміш на основі високомолекулярного метилвінілсилоксанового каучуку
ES2069465A1 (es) Nuevos cooligomeros de piperidin-triazina para utilizar como estabilizadores para materiales organicos.
CO4520207A1 (es) Formulaciones de peroxido de quetona ciclico
SU1786809A1 (ru) Способ получения сополимеров
TW343200B (en) Process for preparing polychlorotrifluoroethylene
WO2002049585A3 (en) High efficacy antiperspirant stick with concentrated elastomer
TNSN89062A1 (fr) Compositions d'aluminophosphates cristallins
UA10985C2 (uk) Дезиhфекційhий засіб

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee